Research – Open Access Philippe Bareille, Susan Tomkins, Varsha Imber, Mohammed Tayob, Karen Dunn, Rashmi Mehta & Sanjeev Khindri Allergy, Asthma & Clinical Immunology volume 16, 11 (2020) Abstract Background To evaluate the effects of fluticasone furoate on the hypothalamic–pituitary–adrenocortical…
Brian Park, PharmD The Food and Drug Administration has granted Fast Track designation to PUR1900 (Pulmazole; Pulmatrix) for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma. ABPA…
Authors: William W. Busse, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Credits Available Physicians – maximum of 0.25 AMA PRA Category 1 Credit(s)™ ABIM Diplomates – maximum of 0.25 ABIM…
Authors: Nicola A. Hanania, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Target Audience and Goal Statement This activity is intended for pulmonologists, allergists & clinical immunologists,…
2020 will be an exciting year for Interasma, the Global Asthma Association, one of this year highlights, among many new developments, being the internationally renowned World Asthma Congress that will…
Case report – Open Access David Clofent, Miquel de Homdedeu, Mariana Muñoz-Esquerre, María Jesús Cruz & Xavier Muñoz Allergy, Asthma & Clinical Immunology volume 16, Article number: 7 (2020) Abstract Background Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight…
This activity is supported by an educational grant from Merck & Co., Inc.0.50 CME 0.50 ABIM MOC 30 MINS $0 FEE Overview Provider Statement This continuing medical education activity is…
Research – Open Access Michael J. McGeachie, Joanne E. Sordillo, Amber Dahlin, Alberta L. Wang, Sharon M. Lutz, Kelan G. Tantisira, Ronald Panganiban, Quan Lu, Satria Sajuthi, Cydney Urbanek, Rachel Kelly, Benjamin Saef, Celeste Eng, Sam S. Oh, Alvin T. Kho, Damien C. Croteau-Chonka, Scott T.…
Brandon May Thickened airway walls, which correlate with airway obstruction and/or occlusion, are greatly increased in patients with severe asthma, according to study results published in the American Journal of Respiratory…
Abstract Objective: To evaluate usability of mepolizumab as a liquid drug product self-administered via a single-use prefilled autoinjector (AI) by patients with severe eosinophilic asthma (SEA), or their caregivers, in-clinic and…